(Axios) – Medical device makers, hospitals and other key health industries are pressing to gain exemptions under the Trump administration’s new tariff regime with the next and most aggressive actions to date due to be unveiled on April 2. Why it matters: About $303 billion of imported drug, biotech and device industry goods entered the United States in the last year — $294 billion of which entered duty-free, according to PwC. (Read More)